Drug Type Small molecule drug |
Synonyms JBI-295 |
Target |
Action inhibitors |
Mechanism HDAC6 inhibitors(Histone deacetylase 6 inhibitors), HDAC8 inhibitors(Histone deacetylase 8 inhibitors), KDM1A inhibitors(Lysine-specific histone demethylase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colonic Cancer | Preclinical | India | 01 Jul 2019 | |
| Leukemia | Preclinical | India | 01 Jul 2019 | |
| Melanoma | Preclinical | India | 01 Jul 2019 | |
| Multiple Myeloma | Preclinical | India | 01 Jul 2019 |





